Lichtman, E. I., Khot, A., Augustson, B., Levitz, D., Sia, H., Doo, N. W., Liedtke, M., Martinet, C., Menon, V., Garton, A., Sembhi, H., Pihlgren, M., Konto, C., Holkova, B., Pacaud, L., Quach, H. (2025). Phase 1, first-in-human study of ISB 2001: A BCMAxCD38xCD3-targeting trispecific antibody for patients with relapsed/refractory multiple myeloma (RRMM)—Dose escalation (DE) results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7514